More Proof that PrEP Works
2021
The EPIC-NSW study of the effectiveness of once-daily tenofovir/emtricitabine for preexposure prophylaxis (PrEP) initially enrolled 3700 predominantly
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI